SV Health Investors

SV Health Investors, formerly known as SV Life Sciences, is a prominent venture capital and growth equity firm based in Boston, Massachusetts, with additional offices in San Francisco and London. Established in 1993, the firm specializes in investing in the healthcare and life sciences sectors, focusing on biotechnology, pharmaceuticals, healthcare services, and medical technology. With over $2 billion in capital under management across multiple private healthcare funds, SV Health Investors has built a strong track record over its 20 years of operation in North America and Western Europe. The firm is dedicated to supporting entrepreneurs who develop innovative solutions and transformative treatments, thereby driving significant advancements in healthcare.

Alex Badamchi-Zadeh

Senior Associate

Josh Baker

Analyst

Michael Balmuth

Managing Partner

Laurence Barker

Partner

Jamil M. Beg

Partner, Biotech Investment Committee Member

Kate Bingham

Managing Partner

Daniel D. Burgess

Venture Partner

Rebecca Canter

Associate

Andrew Cappetta

Associate

James Costine

Partner and Co-CFO (UK) and Chief Risk Officer

Charles Dunn

Principal

Freya Easton

Associate

William Gerard

Analyst

James Glynn

Venture Partner

Eugene Hill

Managing Partner

Lynne Hughes

Venture Partner

Christian Jung

Partner

Jack Kenney

Associate

Dirk Landgraf

Vice President

Paul LaViolette

Managing Partner and COO

Megan MacDonagh

Vice President

Duncan McHale

Venture Partner

Niyoshi Patel

Associate

Ryan Pierce

Venture Partner

Marek Poszepczynski

Investor

David Reynolds

Venture Partner

Michael Ross

Managing Partner

Alfred Rossi

Principal

Alexander Sinclair-Wilson

Analyst

James Summers

Venture Partner

Barbara Tate

Venture Partner

Nikola Trbovic

Partner

Iain Kilty Ph.D

Venture Partner

A.J. Rossi

Principal

Past deals in Guam

U.S. Renal Care

Private Equity Round in 2015
U.S. Renal Care, Inc. is a healthcare service provider that operates a comprehensive network of outpatient, home, and specialty dialysis centers across the United States, serving over 25,000 patients in 335 facilities. Founded in 2000 and based in Plano, Texas, the company specializes in providing both in-center and at-home hemodialysis and peritoneal dialysis for individuals suffering from chronic kidney failure and end-stage renal disease. U.S. Renal Care also manages dialysis programs in acute settings in partnership with local hospitals. The organization emphasizes collaboration with nephrologists through joint venture partnerships to enhance patient care, while also supporting families, caregivers, and healthcare professionals involved in the treatment of kidney disease. The company has a presence in 32 states, including the Territory of Guam.

U.S. Renal Care

Venture Round in 2004
U.S. Renal Care, Inc. is a healthcare service provider that operates a comprehensive network of outpatient, home, and specialty dialysis centers across the United States, serving over 25,000 patients in 335 facilities. Founded in 2000 and based in Plano, Texas, the company specializes in providing both in-center and at-home hemodialysis and peritoneal dialysis for individuals suffering from chronic kidney failure and end-stage renal disease. U.S. Renal Care also manages dialysis programs in acute settings in partnership with local hospitals. The organization emphasizes collaboration with nephrologists through joint venture partnerships to enhance patient care, while also supporting families, caregivers, and healthcare professionals involved in the treatment of kidney disease. The company has a presence in 32 states, including the Territory of Guam.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.